Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma. | Biochem Biophys Res Commun | 2022 | 36030651 | PubTator, text mining | PubMed |
| LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma. | J Exp Clin Cancer Res | 2022 | 36028903 | PubTator, text mining | PubMed |
| ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription. | J Exp Clin Cancer Res | 2022 | 36028854 | PubTator, text mining | PubMed |
| M6A Modifier-Mediated Methylation Characterized by Diverse Prognosis, Tumor Microenvironment, and Immunotherapy Response in Hepatocellular Carcinoma. | J Oncol | 2022 | 36016585 | PubTator, text mining | PubMed |
| A Novel Splice Variant of BCAS1 Inhibits β-Arrestin 2 to Promote the Proliferation and Migration of Glioblastoma Cells, and This Effect Was Blocked by Maackiain. | Cancers (Basel) | 2022 | 36010884 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Glioma. | Biomedicines | 2022 | 36009578 | PubTator, text mining | PubMed |
| RNA Modifications in Gastrointestinal Cancer: Current Status and Future Perspectives. | Biomedicines | 2022 | 36009465 | PubTator, text mining | PubMed |
| Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases. | Biomolecules | 2022 | 36009052 | PubTator, text mining | PubMed |
| Multifaceted Roles of the N6-Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment. | Biomolecules | 2022 | 36008936 | PubTator, text mining | PubMed |
| Long non‑coding RNAs interact with RNA‑binding proteins to regulate genomic instability in cancer cells (Review). | Oncol Rep | 2022 | 36004472 | PubTator, text mining | PubMed |
| N6-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma. | Front Immunol | 2022 | 36003405 | PubTator, text mining | PubMed |
| RNA binding proteins in osteoarthritis. | Front Cell Dev Biol | 2022 | 36003144 | PubTator, text mining | PubMed |
| Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia. | Biomark Res | 2022 | 35999621 | PubTator, text mining | PubMed |
| Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma. | J Nanobiotechnology | 2022 | 35999601 | PubTator, text mining | PubMed |
| Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism. | iScience | 2022 | 35992092 | PubTator, text mining | PubMed |
| Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases. | Mol Ther Nucleic Acids | 2022 | 35991314 | PubTator, text mining | PubMed |
| m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer. | J Immunol Res | 2022 | 35991123 | PubTator, text mining | PubMed |
| Colorectal cancer vaccines: The current scenario and future prospects. | Front Immunol | 2022 | 35990683 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma. | Signal Transduct Target Ther | 2022 | 35989380 | PubTator, text mining | PubMed |
| Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling. | Nat Commun | 2022 | 35987950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=56